跳至主要内容
临床试验/JPRN-UMIN000050999
JPRN-UMIN000050999已完成Unknown

Evaluation of the efficacy and safety of topically applied OC05 cream (221ISC164) in improving wrinkles at the outer corners of the eyes: randomized, single-blind, left-right comparison study. - Evaluation of the efficacy and safety of topically applied OC05 cream (221ISC164) in improving wrinkles at the outer corners of the eyes: randomized, single-blind, left-right comparison study.

Otsuka Pharmaceutical Co., Ltd.0 个研究点目标入组 18 人开始时间: 2023年7月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 60years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1 Subjects with skin conditions that may affect the test results such as urticaria, inflammation, eczema, trauma, acne, pimples, warts, spots, or traces of these. 2 Subjects with atopic dermatitis or a past medical history of atopic dermatitis. 3 Subjects who have received or intend to receive aesthetic operations such as Botox, hyaluronic acid or collagen injections, or photofacials during the study period. 4 Subjects who have received or intend to receive skin care treatments at the spa within the last four weeks or during the study period. 5 Subjects who regularly use moisturizers such as cream or all-in-one products and masks, excluding lotion and milky lotion products. 6 Subjects who regularly use cosmetics or ingest foods that are containing vitamin C at the test sites. 7 Subjects who regularly use cosmetics or ingest foods claiming anti-wrinkle efficacy at the test sites. 8 Subjects who have changed or started using a new cosmetic or sunscreen product within the last four weeks. 9 Subjects who have been exposed to ultraviolet light in excess of the dose they could be exposed to on a daily basis, by prolonged outdoor work, exercise, swimming or recreational activities, within the past four weeks, or plan to do so during the test period. 10 Shift workers working on night shifts or rotating day and night shifts. 11 Subjects who are undergoing treatment such as hormone replacement therapy, drug therapy, exercise therapy, diet therapy in a medical institution, or who are diagnosed to require such treatment at the time of obtaining consent. 12 Subjects with past medical history of diseases related to glucose metabolism, lipid metabolism, liver function, renal function, heart function, circulatory system, respiratory system, endocrine system, immune system, nervous system or mental illness. 13 Subjects with a past history of drug or alcohol dependence.

研究者

相似试验